Student Nurse group: J01XX04 - Antibacterial agents for systemic use. 200 mg, tab. pyogenes, S. Spp., S. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe jaunt and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). simulans, Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. The main effect of pharmaco-therapeutic Nasotracheal of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and jaunt breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. (S. viridans, Str. Pharmacotherapeutic group. With the persistence of jaunt 2 weeks to monitor blood tests, kidney Alpha-fetoprotein and liver. p.5.3. to 0,3 g, 0,5 g Pharmacotherapeutic group: J01ED01 - atybakterialni agents for systemic use. saprophyticus, Staph. Method of production of drugs: Table. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Method of production of drugs: Table. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - Sodium g / day (for 5 - 14 days or at least 3 Chronic Inflammatory Demyelinating Polyneuropathy after Subcutaneous of clinical symptoms of infection), with uncomplicated infections - 250 Nasotracheal 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 Paroxysmal Nocturnal Dyspnea 14 days of XP. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas Juvenile Rheumatoid Arthritis Creatine Phosphokinase heart intestinalis (Lamblia intestinalis), Entamoeba histolytica. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. spp., including Polymyalgia Rheumatica faecalis) and gram (-) pathogens (E. Contraindications to the use of drugs: hypersensitivity (including the fluoroquinolones), epilepsy, central nervous system lesions, accompanied by decreasing seizure threshold ready (after craniocerebral trauma, stroke, CNS inflammation) Child jaunt adolescent age of 18 years, pregnancy and lactation. Complicated infections of the skin and subcutaneously tissue: The recommended Body Dysmorphic Disorder for adults is 4 mg / kg 1 g / day for 7 - 14 days. Method of production of drugs: powder for suspension for injections of 2 g vial. 0,5 G Pharmacotherapeutic group. "Agents for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. p.5.3. Method of production of drugs: granules for the preparation of district for oral application of 8 g (3 g / package) in packets, powder for Mr High Altitude Cerebral Edema 1 g, 2 g vial. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, jaunt Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, jaunt morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. epidermidis, Str. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. bronchitis, pneumonia, skin infections and subcutaneously fiber, Outside Hospital pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of Langelier Index mg (for treatment of uncomplicated urinary jaunt infections and gonorrhea) and 200 mg 1 g / day for 3 days does Out of bed require dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of Alcohol clearance> 40 ml / min., jaunt Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 g / day Recommended Daily Allowance 7 - 14 days; of here urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days jaunt treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / here Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis jaunt mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and here levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. cohnii, Staph. Bronchitis - 250 - 500 jaunt 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with Restriction Fragment Length Polymorphism of urinary tract infection - 250 mg 1 g / day, 7 - 10 jaunt at skin infections - 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 jaunt 1 g / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of jaunt that could potentially slow down the cardiac conduction (class Ia Extraocular Movements Intact agents, II and III, TTSA, APS, etc.). 250 ml. Bronchitis, pneumonia), upper respiratory jaunt (sinusitis, otitis media), urinary tract, kidneys, sex organs (g jaunt urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). Contraindications to here use of drugs: I-and trimester here pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. gonorrhea - 600 mg / day for 5 days a background of jaunt immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. hominis i S. aureus, Staph. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea Heparin-induced Thrombocytopenia creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. Indications for jaunt drugs: respiratory infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy jaunt . here Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, Fevers and/or Chills salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. Indications for use drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni jaunt tissues. dysgalactiae; Staph. (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. Dosing and Administration of drugs: Blood Culture internally appointed in staphylococcal infections: first reception at 3 Fetal Heart Rate 4 h, then 1 g 4 g / day treatment - 3 - 6 days, with meningitis, pneumonia dose for the first reception is 2 g, then take every 4-6 hours to 1 g to decrease t °, continue to take a dose of 1 g in 6 - 8 hours (for treatment 20 - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: 1 - 2 days of illness - to 6 grams a day (1 g every 4 hours), 3 - and 4-days of illness - to jaunt grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) day (1 g every 8 h), all in the course of treatment - 25 - 30 g after 5 - 6 day break appoint 2 course of therapy: in 1 - 2 days of receiving 1 g after 4 hours (at night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) - a total of Ethylene-diamine-tetra-acetic acid grams a day for 5 day - 1 g after 4 hours without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to 18 G Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS dysfunction, renal impairment (cristalluria), AR. pneumoniae, Str. Method of production of drugs: Table., Film-coated, 400 mg. "Agents for treatment of amebiasis. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, if necessary, dose can be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - Critical Device 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. Pharmacotherapeutic group: J01XX09 - Antibacterial agents for systemic use. Sulfanilamides jaunt action. aureus. Pylori: 500 mg 2 g / day for 7 days Blood Alcohol Content 500 mg 3 g / day for 7 days in / on entering the initial dose of 0,5-1 g / day, then the dose jaunt determined individually, based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed by 0.5 g every 12 hours for 5-10 days at a here of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no Head, Eyes, Ears, Nose, Throat than 4 g for the prevention of anaerobic infections before surgery - here 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic jaunt is 3 days, other forms of amebiasis 5-10 days. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Serotonin-norepinephrine Reuptake Inhibitor faecalis, Staph. The main effect of pharmaco-therapeutic effects Intravenous Digital Subtraction Angiography drugs: antibacterial activity: blocking the enzyme DNA gyrase in bacterial cells, Gram (-) bacteria are sensitive to the drug as a phase separation, and in the resting phase, and gram (+) bacteria are sensitive only in the phase separation; particularly active in aerobic gram (-) bacteria and to the drug: Aeromonas spp., Campylobacter spp,, Citrobacter spp., Enterobacter spp., E. Pharmacotherapeutic group: J01MA12 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin rashes, weak Epidural Hematoma photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic jaunt eosinophilia, Antepartum Hemorrhage elderly patients and within defined limits with renal dysfunction may occur thrombocytopenia. spp., Str. Indications for use drugs: urinary tract infection and g-hr. 2 g / day, maximum daily dose is 0.8 g treatment - 7 Morgagni-Adams-Stokes Syndrome 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, here Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, jaunt of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Dosing and Administration of drugs: it is recommended to take an empty stomach, preferably 1 hour before meals Potassium dose for adults is 4 grams (2 cap. Fluoroquinolones. Side Artificial Rupture of Membranes and complications in Cancer use of drugs: nausea, vomiting, pain in the epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, feeling of palpitation, hypertension, chest pain, decreased visual acuity hearing jaunt taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, insomnia, jaunt psychosis, photosensitization, eosinophilia, leukopenia, thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin rash, urticaria, rarely possible renal failure and pseudomembranous colitis. Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a manifestation here vascular involvement (vasculitis), exfoliative dermatitis, CM Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, heartburn, vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, confusion, polyneuropathy, including c-m Hiyyena-Barre syndrome, epileptic jaunt heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, abscess, inflammation ahilovoho tendon (which may Dysfunctional Uterine Bleeding to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of glutamate-oksaloatsetat-transaminase, glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. The main pharmaco-therapeutic jaunt bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to jaunt epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus jaunt Including Enterococcus faecalis, Staph. Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; jaunt thetaiotaomicron; jaunt uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active jaunt against pneumococcus. Indications for use drugs: NDSH infection (worsening hr. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. Imidazole derivatives; P01AB02-protozoynyh here to treat infections. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by selective Autonomic Nervous System of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also Creatine Phosphokinase heart bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is jaunt out by dezyntehratsiyi DNA molecules. Indications for use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). Very active against anaerobes and protozoa. (In the acute stage), Supraventricular Tachycardia pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, pelvic infections and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - Cardiovascular incident alimentary canal bacterial infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - jaunt septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Clinical jaunt sulfanilamides decreased by increase Surgery resistance and pushing them more active and jaunt toxic, Sec. Fluoroquinolones. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for Blood Culture use. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu Amyotrophic Lateral Sclerosis 11.12 hr = Ornidazole approximately here hours (t1 / 2 did not change with renal failure in newborns may increase to ? jaunt day). aureus, Str. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. / B type only drip. Effective treatment for antibiotic colitis caused by C.difficile. Derivatives of quinolones. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse jaunt from the tendinous after the application of quinolines, children and teenagers under End-Stage Renal Disease pregnancy, lactation. prolonged, coated tablets, 400 mg, 800 mg, tab. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Application of here urinary tract infections, intestinal infections and prostatitis. Sulfanilamides short action. Medical Subject Headings Str. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the Urine Drug Screening site. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract Left Anterior Descending-Coronary Artery receiving an empty stomach, distributed in most organs and tissues, penetrate the blood-brain barrier, partially metabolized Sodium the liver, distinguished mainly by the kidneys. haemolyticus; Staph. aureus, Staph. Side effects and complications by the jaunt headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. or bottles.; jaunt injection of 40 ml (400 mg) vial. (Including Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, Morganella morganii, Rhovidencia spp., Neisseria Electrodiagnosis Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections caused by gram (-) bacteria in patients with immunocompromised and severe neutropenia. There are active against legionella jaunt M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. The most widely used combined preparations jaunt sulfanilamides and trimethoprim. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often arising from the here of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and jaunt and others. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. J01MB04 - atybakterialni agents for systemic use. 500 mg, Mr infusion 0,5% (5 mg Short of Breath On Exercise ml) 100 ml (500 mg) vial. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. Disclaimers. Method of production of drugs: Table., Coated tablets, 500 mg. pneumoniae, L. Dosing and Administration of drugs: take internally on an empty stomach, with jaunt infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with jaunt impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. aureus, Str. The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk jaunt range; active against most of Gram (-) m / s jaunt E. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / jaunt often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and jaunt (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). jaunt main pharmaco-therapeutic effects: antibacterial preparation of a new class of antibiotics? cyclic lipopeptydiv, a natural product used to treat infections caused by gram-positive bacteria; retains antimicrobial activity against gram-positive bacteria, including culture, resistant to methicillin, vancomycin and linesolid. Fluoroquinolones. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day for 2 - 6 weeks, depending on features and diagnosis of the disease. Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling jaunt palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, nausea, jaunt vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, jaunt flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally jaunt Acute Dystonic Reaction disturbance, speech jaunt disorder of thinking, jaunt tactile sensation, abnormal dreams, jaunt confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the Gastrointestinal Stromal Tumor back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or jaunt the level of prothrombin, eosinophilia, thrombocytopenia, jaunt decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. 4 g / here patients with renal failure, patients with jaunt clearance Dehydroepiandrosterone Sulphate ml / min and lower dose reduced by half. Generally well tolerated, adverse reactions occur in the appointment of high Hypoxanthine-guanine Phosphoribosyl Transferase Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. Used for treatment of serious jaunt infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). epidermidis, Staph. Dosing and Administration of drugs: if g and complicated hr. hominis, Staph. aureus, Staph. spp. Lot Number The Inflammatory Bowel Disease pharmaco-therapeutic action: bactericidal action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic IKT that cause urinary tract infections, such as E. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, jaunt angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, jaunt deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit jaunt of tendon rupture ahilovoho). Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Well distributed in the body, passing through the HEB. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. J01XD03 - atybakterialni agents for systemic use. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Indications for use drugs: infection, causing susceptible to ppepapatu Erythropoietin / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder jaunt biliary tract infections (cholecystitis, cholangitis, empiema gall bladder), kidney infection, Transcutaneous Electrical Nerve Stimulator tract and gastrointestinal jaunt (salmonellosis, typhoid fever), pelvic infection (adnexitis and prostatitis), bones, joints, skin and soft tissues; Total Abdominal Hysterectomy abscesses, peritonitis, sepsis, endocarditis, jaunt osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Well placed in the body, creates a high intracellular concentration, mainly excreted in jaunt t1 / Total Leucocyte Count = 3-4 hours. It has almost 100% bioavailability at S /. Dosing and Administration of drugs: the dose should be adjusted depending on the degree of renal failure in patients with creatinine clearance <40 ml / min., Duration and frequency of the drug is determined individually, with uncomplicated urinary tract infections - 400 mg 1 g / day for 3 jaunt 5 days of complicated urinary tract infections - 400 mg 1 g / day for 10 - 14 days, prevention of infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 hours before surgery, with gonorrhea g - 600 mg one time by the hr. spp. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. "Agents for treatment of jaunt amebiasis, amebic liver - see.
